SDK002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SDK002, covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma. [Phase 1]